USPTO 2015–2025 USPTO PatentsView US Corporation

Xcella Biosciences, Inc.

USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

24.5

Avg claims per patent

+300%

5-year filing velocity

The verdict

Xcella holds 10 US patents across 8 technology areas, rank #27,831 of 50,000 tracked assignees.

#27,831
of 50,000 US assignees by volume: Top 32%
by Innovation Score (41.9/100): 24.5
avg claims per patent: +300%
filing velocity, last 5 yrs

Portfolio overview

Xcella Biosciences, Inc. has been granted 10 US utility patents between 2018 and 2025, placing Xcella Biosciences, Inc. at rank #27,831 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.5 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Xcella Biosciences, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Xcella sits between Wooshin Safety Systems Co., Ltd. (10 patents, rank #27,827) and Xiamen GHGM Electric Co., Ltd (10 patents, rank #27,835) - the closest US assignees by grant volume. The composite Innovation Score of 41.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 2 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Xcella Biosciences, Inc.'s 24.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Xcella Biosciences, Inc. against peers pursuing similar technology classes.

Wooshin Safety Sy…

10
Wostec

10
Wrightspeed

10
X-therma

10
Xenon

10
XG Sciences

10
Xi'an Modern Chem…

10
Xiamen GHGM Elect…

10
Xcella Biosciences ◀

10

What this shows Xcella holds 10 patents at rank #27,831, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xcella

By rank, the assignees closest to #27,831 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Xcella's primary technology class.

Xcella's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Xcella Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	10.0%
2019	1	10.0%
2021	2	20.0%
2022	2	20.0%
2023	1	10.0%
2024	1	10.0%
2025	2	20.0%

Which technologies does Xcella Biosciences, Inc. patent most?

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 8

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 7

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 4

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 4

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 2

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 2

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

Top 8 of 8 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#27,831

Across all tracked assignees

Innovation Score

41.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Xcella Biosciences, Inc. hold?

Xcella Biosciences, Inc. holds 10 US granted patents filed between 2018 and 2025, spanning 8 technology areas.

What is Xcella Biosciences, Inc.'s Innovation Score?

Xcella Biosciences, Inc. has an Innovation Score of 41.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Xcella Biosciences, Inc. focus on?

Xcella Biosciences, Inc.'s top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 10 patents. The company has filed patents in 8 CPC subclasses total.

Is Xcella Biosciences, Inc.'s patent filing rate increasing or decreasing?

Xcella Biosciences, Inc.'s recent filing velocity is +300% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Xcella Biosciences, Inc.'s patents?

Xcella Biosciences, Inc.'s patents average 24.5 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Xcella Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Xcella's 10 grants land it in the top 32% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Xcella ranks #27,831 of 50,000. Top 50 holders
Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.